12/18
10:43 am
bntc
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
Medium
Report
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
12/17
06:28 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Low
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
12/16
07:05 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
12/16
07:05 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
12/13
07:49 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.
12/9
11:58 am
bntc
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? [Yahoo! Finance]
Low
Report
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? [Yahoo! Finance]
12/9
10:49 am
bntc
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Medium
Report
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
12/3
11:45 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $17.00 price target on the stock.
Neutral
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $17.00 price target on the stock.
11/26
07:00 am
bntc
Benitec Biopharma to Participate in Upcoming Investor Conferences in December
Low
Report
Benitec Biopharma to Participate in Upcoming Investor Conferences in December
11/14
04:37 pm
bntc
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]
Low
Report
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]
11/14
04:30 pm
bntc
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
Low
Report
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
11/4
08:00 am
bntc
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference
Low
Report
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference
10/18
03:34 pm
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "overweight" rating re-affirmed by analysts at Piper Sandler.
Low
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "overweight" rating re-affirmed by analysts at Piper Sandler.
10/17
11:03 pm
bntc
Benitec Biopharma: OPMD Program Continues To Advance With Catalysts [Seeking Alpha]
Medium
Report
Benitec Biopharma: OPMD Program Continues To Advance With Catalysts [Seeking Alpha]
10/16
07:39 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.
Low
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.
10/14
08:41 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $16.00 to $18.00. They now have a "market outperform" rating on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $16.00 to $18.00. They now have a "market outperform" rating on the stock.
10/14
06:00 am
bntc
Benitec Biopharma Announces Updated Investor Webcast Information
Medium
Report
Benitec Biopharma Announces Updated Investor Webcast Information
10/12
06:30 am
bntc
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society
Medium
Report
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society
10/9
01:48 am
bntc
Benitec Biopharma's BB-301: Potential In OPMD But Still Too Early Stages [Seeking Alpha]
Low
Report
Benitec Biopharma's BB-301: Potential In OPMD But Still Too Early Stages [Seeking Alpha]
9/30
10:08 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock.
Low
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock.
9/28
10:57 am
bntc
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Low
Report
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
9/26
04:30 pm
bntc
Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update
Medium
Report
Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update